Enacted — Signed by the President — Jul 9, 2012
Last Action: Signed by President.
Explanation: This bill was enacted after being signed by the President on July 9, 2012.
GovTrack Insider, our Kickstarter-backed work to summarize bills in Congress, has resumed. Here’s what we’ve been up to:
Feb 8, 2012
112th Congress, 2011–2013
This bill was introduced on February 8, 2012, in a previous session of Congress, but was not enacted.
Representative for Pennsylvania's 18th congressional district
Read Text »
Last Updated: Feb 8, 2012
Length: 88 pages
To amend the Federal Food, Drug, and Cosmetic Act to establish user-fee programs for generic drugs and biosimilars.
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 3988”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Enacted — Signed by the President
Jul 9, 2012
Last Action: May 30, 2012
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2016). H.R. 3988 — 112th Congress: Generic Drug and Biosimilar User Fee Act of 2012. Retrieved from https://www.govtrack.us/congress/bills/112/hr3988
“H.R. 3988 — 112th Congress: Generic Drug and Biosimilar User Fee Act of 2012.” www.GovTrack.us. 2012. February 7, 2016 <https://www.govtrack.us/congress/bills/112/hr3988>
|title=H.R. 3988 (112th)
|accessdate=February 7, 2016
|author=112th Congress (2012)
|date=February 8, 2012
|quote=Generic Drug and Biosimilar User Fee Act of 2012